Ophthalmic Consultants of Long Island Celebrates One Year in Advancing the Science of Laser Refractive Cataract Surgery

Share Article

One year ago Dr. Eric Donnenfeld performed first case in New York using the femtosecond laser for customized refractive cataract surgery.

One year ago, Long Island and New York’s first laser enhanced and customized cataract surgery was performed by Dr. Eric Donnenfeld at Island Eye Surgicenter in Carle Place.

Laser refractive cataract surgery is without a doubt the most technologically advanced option for cataract patients

One year ago, Long Island and New York’s first laser enhanced and customized cataract surgery was performed by Dr. Eric Donnenfeld at Island Eye Surgicenter in Carle Place. Dr. Donnenfeld, a founding partner of Ophthalmic Consultants of Long Island (OCLI) and clinical professor of ophthalmology at NYU, is one of only a handful of surgeons in the U.S. experienced with this laser. Drs. Henry Perry, David Nelson, Eric Donnenfeld, Russell Fumuso, Ronald Caronia, Gerard D’Aversa, Robert Broderick, Joseph Bacotti and Jack Oats are now trained to perform the surgery and in the past year OCLI has performed hundreds of surgeries at Island Eye Surgicenter and patients from all over the world have come to this center for advanced cataract surgery. Island Eye Surgicenter was only the third surgical facility in the US to perform this advanced technology. Cataract surgery is the most commonly performed operation in the United States with over 3 million cases performed annually. Today, visual rehabilitation following cataract surgery may be significantly enhanced with a laser surgical procedure and specialized implant designed to correct refractive error. The addition of this exciting laser technology adds a new level of precision and predictability to the procedure that simply was not possible with conventional manual surgery.

Each human eye is different in terms of size, depth, curvature of the cornea and other key features. Before cataract surgery, every eye is carefully measured and mapped. The Alcon LenSx laser uses a combination of highly advanced technologies to capture incredibly precise, high-resolution digital images of the eye. These images and the measurements and data they provide are then used to plan and perform a surgery to exacting specifications that were previously unachievable with traditional (manual) cataract surgery.

In addition, the LenSx laser adds computer-control to key steps of cataract surgery, ensuring highly precise surgical incisions. The unique software analyzes high-resolution images of the eye which then enables the surgeon to design a customized, image-guided procedure for every patient and then execute the laser procedure on command.

“Laser refractive cataract surgery is without a doubt the most technologically advanced option for cataract patients,” said Dr. Eric Donnenfeld. “Before this technology was available, many of the most challenging steps during cataract surgery were performed manually with a blade. With the LenSx laser, we can offer our patients a truly premium experience with the precision and reliability of a laser for refractive cataract surgery.”

The LenSx laser is the first FDA approved femtosecond laser for cataract surgery, which can very accurately perform anterior capsulotomies, corneal incisions and lens disruption. Prior to the introduction of this breakthrough technology, all of these steps were performed manually with handheld blades or ultrasound energy.

To learn more about customized laser cataract surgery and refractive surgical options using the LenSx laser technology, visit http://www.ocli.net. To schedule an appointment with Dr. Eric Donnenfeld or another OCLI cataract surgeon, please contact 1-866-SEE-OCLI (1-866-733-6254).

About Ophthalmic Consultants of Long Island
OCLI, one of the largest ophthalmology practices in the nation, consists of 24 eye doctors and specialists representing most subspecialties of ophthalmology and optometry in 9 locations throughout Long Island; in Rockville Centre, Lynbrook, Valley Stream, East Setauket, Manhasset, East Meadow, Port Jefferson, Mineola and Inwood. OCLI also has a research department that is involved in FDA studies to improve the treatment and diagnosing of ophthalmic diseases. For more information, please call 1-866-SEE-OCLI (1-866-733-6254) or visit http://www.ocli.net.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sara Rietbroek
InfiniTech Public Relations
516 829 5502
Email >
Visit website